DARZALEX FASPRO® and DARZALEX® for newly diagnosed multiple myeloma
Studies have shown that DARZALEX FASPRO® and DARZALEX® are both treatment options for people with newly diagnosed multiple myeloma. This includes people who are eligible to receive a stem cell transplant and those who are not.
Learn more here about DARZALEX FASPRO® treatment
for those people who are eligible to receive a stem cell transplant.
Learn more here about DARZALEX FASPRO® and DARZALEX® treatment
for people who are not eligible to receive a transplant.
How DARZALEX® or DARZALEX FASPRO® may potentially be incorporated into your treatment regimen
Treatments are often combined because they fight the cancer and/or symptoms in different ways. It’s common to be on a combination of 2 or more drugs.
- Four drugs at the same time is called a quadruplet (quad) regimen.
- Taking 3 medicines at the same time is called a triplet regimen.
Your doctor will decide what is the right regimen for you based on your Revised International Staging System (R-ISS) stage as well as the effectiveness and safety of each medicine.
Some examples of how these medicines can be combined for your individual treatment regimen include:
Quad Regimen
Triplet Regimen
Doublet Regimen
Monoclonal antibody
Proteasome inhibitor
Corticosteroid
Immunomodulatory agent
Watch real patients talk about how DARZALEX FASPRO® and DARZALEX® have worked for them.
